(c) 2022 PillSync.com

pitavastatin magnesium 1 MG Oral Tablet Zypitamag

1 INDICATIONS AND USAGE ZYPITAMAG is indicated as an adjunctive therapy to diet in adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C). Limitations of Use The effect of ZYPITAMAG on cardiovascular morbidity and mortality has not been determined. Pediatric use information is approved for Kowa Co Ltd’s LIVALO (pitavastatin) tablets. However, due to Kowa Co Ltd’s marketing exclusivity rights, this drug product is not labeled with that information. ZYPITAMAG is an HMG-CoA reductase inhibitor indicated as an adjunctive therapy to diet in adult patients with primary hyperlipidemia or mixed dyslipidemia to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C) Limitations of Use : The effect of ZYPITAMAG on cardiovascular morbidity and mortality has not been determined.

Medicure International Inc


2 years ago ROUND WHITE 876 pitavastatin magnesium 1 MG Oral Tablet Zypitamag

ROUND WHITE 876

16 HOW SUPPLIED/STORAGE AND HANDLING ZYPITAMAG (pitavastatin) Tablets, 2 mg are white to off-white, beveled-edge, round-shaped tablets debossed with “877” on one side and plain on the other side and are supplied as follows: NDC 25208-201-13 in bottle of 30 tablets with child-resistant closure NDC 25208-201-09 in bottle of 90 tablets with child-resistant closure NDC 25208-201-14 in bottle of 100 tablets NDC 25208-201-15 in bottle of 500 tablets NDC 25208-201-11 in bottle of 1000 tablets NDC 25208-201-12 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets ZYPITAMAG (pitavastatin) Tablets, 4 mg are white to off-white, beveled-edge, round-shaped tablets debossed with “878” on one side and plain on the other side and are supplied as follows: NDC 25208-202-13 in bottle of 30 tablets with child-resistant closure NDC 25208-202-09 in bottle of 90 tablets with child-resistant closure NDC 25208-202-14 in bottle of 100 tablets NDC 25208-202-15 in bottle of 500 tablets NDC 25208-202-11 in bottle of 1000 tablets NDC 25208-202-12 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets Storage Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature]. Protect from moisture and light.

More pills like ROUND 876

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site